TrialPloS one2018

ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.

Eva-Maria Ratai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.